IFNA1 and neoplasm: Here, we show for the first time to our knowledge that Sl-IFN, as monotherapy or in combination with chemotherapy, stimulates antitumor immune responses in both transplantable tumor models and NeuT transgenic mice spontaneously developing SDC.